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Summary
Inhibition of kinesin-5, a mitotic motor protein also ex-
pressed in neurons [1], causes axons to grow faster as a re-
sult of alterations in the forces on microtubules (MTs) in the
axonal shaft [2–4]. Here, we investigate whether kinesin-5
plays a role in growth-cone guidance. Growth-cone turning
requires that MTs in the central (C-) domain enter the periph-
eral (P-) domain in the direction of the turn. We found that
inhibition of kinesin-5 in cultured neurons prevents MTs
from polarizing within growth cones and causes them to
grow past cues that would normally cause them to turn.
We found that kinesin-5 is enriched in the transition (T-)
zone of the growth cone and that kinesin-5 is preferentially
phosphorylated on the side opposite the invasion of MTs.
Moreover, when a growth cone encounters a turning cue,
phospho-kinesin-5 polarizes even before the growth cone
turns. Additional studies indicate that kinesin-5 works in
part by antagonizing cytoplasmic dynein and that these
motor-driven forces function together with the dynamic
properties of the MTs to determine whether MTs can enter
the P-domain. We propose that kinesin-5 permits MTs to se-
lectively invade one side of the growth cone by opposing
their entry into the other side.
Results and Discussion
Effects of Kinesin-5 Inhibition on Growth-Cone Turning
To test whether kinesin-5 (also called Eg5) is involved in
growth-cone turning, we first used the ‘‘border assay,’’ which
utilizes a glass coverslip with a sharp border between a lami-
nin-coated side and a polylysine-coated side. When explants
of rat sympathetic ganglia are plated on the laminin side,
growth cones normally turn when they reach the border.
Indeed, almost all axons turned at the border in the case of
dimethyl sulfoxide (DMSO)-treated control neurons. However,
very few axons turned in the presence of monastrol, an alloste-
ric inhibitor of kinesin-5 [5] (Figures 1A–1C). Instead, the
growth cones ignored the border, crossed it, and continued
growing on the polylysine side. This effect was quantified by
measurement of the fluorescence for the immunostained
MTs on each side of the coverslip. The ratio of MT fluores-
cence pixels per unit area of axons that crossed the border
and axons that turned at the border was 0.0232 6 0.008
(n = 7) and 0.790 6 0.046 (n = 11), respectively, for control
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0.0001, two-tailed t test). The same result was obtained with
explants of chicken dorsal root ganglia (DRG) (data not
shown).
Qualitatively similar results were obtained when siRNA was
used to deplete kinesin-5 from the neurons. Previous quantita-
tive studies demonstrated that this approach depletes over
95% of kinesin-5 [4]. The ratio of MT fluorescence for controls
(in this case, control siRNA) and kinesin-5-depleted cultures
was 0.0916 0.005 (n = 7) and 0.7686 0.039 (n = 7), respectively
(p % 0.001, two-tailed t test), which is an 8.44-fold increase
(Figure 1D). Thus, either depletion or inhibition of kinesin-5
results in a dramatic inhibition of growth-cone turning in
response to substrate cues.
The growth cones of chicken DRGs turn toward NGF-coated
polystyrene beads [6]. In DMSO-treated control cultures
(n = 19), the growth cones that made contact with an NGF-
coated bead typically turned toward the bead (in 79% of the
cases). In monastrol-treated cultures (n = 14), growth cones
that contacted beads turned only in 14% of the cases (p %
0.001, chi-square test). The growth cones in these monas-
trol-treated cultures showed no reaction upon encountering
the bead but, instead, advanced forward, past the bead,
without turning (Figures 1E-1G). Thus, inhibition of kinesin-5
curtails growth-cone turning in response to either growth
factors or substrate cues.
Effect of Kinesin-5 Inhibition on Microtubule Distribution
during Growth-Cone Turning
Next, we studied MT distribution in the bead assay. Growth
cones of control neurons displayed a polarized MT array,
with abundant MTs invading the P-domain on the side of the
growth cone in the direction of the bead. There were fewer
MTs invading the other side of the growth cone, away from
the bead (Figures 1H and 1H0). By contrast, the monastrol-
treated neurons displayed no such bias on one side of the
growth cone or the other with respect to MT distribution
(Figures 1I and 1I0). The MT Distribution Ratio (MDR; see Sup-
plemental Experimental Procedures, available online) was 2.43
in control growth cones (n = 13) and 1.10 in monastrol-treated
growth cones (n = 14) (p < 0.009) (Figure 1J). Analysis of the
percentage of NGF-coated beads contacting axons that
elicited filopodial sprouting [6] and the number of filopodia
associated with each NGF-coated bead failed to reveal a differ-
ence, suggesting that monastrol did not alter the response
of the filamentous actin to the NGF-coated beads (data not
shown). These results suggest that kinesin-5 is crucial for the
ability of growth cones to alter their MT distribution in
response to a turning cue.
Microtubule Behaviors inGrowth Cones after Experimental
Manipulations of Kinesin-5 and Cytoplasmic Dynein
To visualize and quantify MT behaviors in growth cones,
we quantified the number and velocity of the EGFP-EB3
‘‘comets’’ within filopodia of EGFP-EB3-transfected neurons,
as described previously [7–9]. Quantification over the course
of 3 min showed significantly more comets (with a higher
velocity) in filopodia of kinesin-5-depleted growth cones as
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1973Figure 1. Inhibition of Kinesin-5 Inhibits Growth-
Cone Turning at a Laminin-Polylysine Border,
Inhibits Turning toward NGF-Coated Beads,
and Prevents Reorganization of MTs in Response
to NGF-Coated Beads
(A and B) Axons (green, tubulin) grow on laminin
(red), and their growth cones reach the border.
(A) Growth cones of control explants treated
with 0.1% DMSO turn at the border. (B) In the
presence of 100 mM monastrol, most growth
cones cross the border. Scale bar represents
15 mm.
(C) Quantification of the ratio of MT fluorescence
on polylysine (axons that crossed the border) and
laminin (axons that turned at the border) shows
a significant increase in cultures treated with mo-
nastrol (red bar) compared to DMSO (blue bar).
Asterisk denotes p % 0.0001. Data represented
as mean 6 SEM.
(D) Quantification of the ratio of MT fluorescence,
as above, shows that when kinesin-5 was
depleted with the use of siRNA, a result similar
to that obtained with monastrol treatment was
observed. Asterisk denotes p% 0.001. Data rep-
resented as mean + SEM.
(E and F) Time-lapse phase-contrast images of
growth cones of chicken DRG explants treated
with DMSO (control) or monastrol for inhibition
of kinesin-5. (E) Example of a growth cone,
treated with 0.1% DMSO, turning toward the
NGF-coated bead. (F) Example of a growth
cone, treated with 100 mM monastrol, that
had contacted the NGF-coated bead but did
not turn toward the bead. Scale bar represents
10 mm.
(G) Percentage of growth cones that turned
toward the NGF-coated bead. Asterisk denotes
p% 0.001.
(H and I) Examples of MT (green) and actin (red)
organization in a DMSO-treated growth cone
(H and H0) and a monastrol-treated growth cone
(I and I0) contacting an NGF-coated bead. The
axonal axis (see Supplemental Experimental Pro-
cedures) is depicted as a blue line. Bead loca-
tions are shown as dotted circles denoting the
circumference of the beads. The control growth
cone shows an increased MT distribution toward
the contact point with the bead, but the monas-
trol-treated growth cone does not show any
marked asymmetry in MT distribution.
(J) Quantification of the MDR (as defined in Sup-
plemental Experimental Procedures) in control
and monastrol-treated growth cones. The blue
bar indicates the MDR in control growth cones
that contact the bead. The red bar indicates the
monastrol-treated growth cones that contact
the bead. The yellow and green bars indicate
growth cones that do not contact beads in the
cases of control and monastrol-treated growth
cones, respectively. Asterisk denotes p < 0.009.
Scale bar represents 10 mm. Data represented
as mean + SEM.
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(A–D) Examples of fluorescence micrographs. (A) Neuron transfected with control siRNA and treated with DMSO. (B) Neuron transfected with DHC siRNA
and treated with DMSO. (C) Neuron transfected with control siRNA and treated with monastrol. (D) Neuron transfected with DHC siRNA and treated with
monastrol. Scale bar represents 5 mm.
(E) Graph showing the number of EB3 comets that enter the filopodia in growth cones. Single asterisk denotes p% 0.01; double asterisk denotes p% 0.001.
(F) Graph showing the velocity of EB3 comets that enter the filopodia. Single asterisk denotes p% 0.01; double asterisk denotes p% 0.005. (E and F) Red
bars indicate neurons transfected with control siRNA and treated with DMSO. Blue bars indicate neurons simultaneously depleted of DHC and treated
with DMSO. Yellow bars indicate neurons treated with the combination of control siRNA and monastrol, and green bars indicate neurons treated with
the combination of DHC siRNA and monastrol. Data represented as mean + SEM.compared to control growth cones. These results, shown in
Figure S1, suggest that kinesin-5 normally opposes the entry
of MTs into filopodia.
Recent studies have shown that forces generated by cyto-
plasmic dynein enable MTs to overcome myosin-II-based
retrograde flow and enter the P-domain, which includes the
filopodia [7–9]. Forces generatedby kinesin-5 have beenshown
to oppose forces generated by cytoplasmic dynein during
mitosis [10] and in MT asters [11]. To investigate whether the
same is true in growth cones, we treated rat sympathetic neu-
rons with control siRNA or dynein heavy chain (DHC) siRNA for
2 days as described previously, [12] then replated the neurons
and allowed them to grow axons anew for 7 hr in either DMSO
or monastrol. Under these conditions, DHC levels were
reduced by roughly 90%, as shown by western blot [12]. After
replating, the cultures were exposed to either monastrol or
DMSO.
In results similar to those obtained in the siRNA-based
depletion studies, quantification of the number of comets
that invaded per filopodium (Figure 2E) during the course of
3 min showed a significant increase in of monastrol-treated
growth cones (22.78 6 2.72, n = 9) as compared to DMSO-
treated growth cones (6.46 0.86, n = 15) (p% 0.001, two-tailed
t test) (Figures 2A and 2C). In the case of DHC-depleted
neurons, the number of comets was 1.3 6 0.51 (n = 12) in
the presence of the DMSO and increased nearly 13-fold, to
16.556 1.01 (n = 11), in the presence of monastrol (p% 0.001,
two-tailed t test; Figures 2B, 2D, and 2E). Also, the velocity of
EB3 comets in the filopodia (Figure 2F) was increased in mon-
astrol-treated growth cones (0.0357 6 0.005 mm/sec)compared to control growth cones (0.014 6 0.003 mm/sec)
(p% 0.005, two-tailed t test). When dynein-depleted neurons
were treated with monastrol, EB3 comet velocity was higher
(0.023 6 0.005 mm/sec) than comet velocities measured in
growth cones of neurons treated with either control or DHC
siRNA alone (0.0065 6 0.002 mm/sec) (p % 0.01, two-tailed t
test). These results are consistent with a mechanism wherein
kinesin-5 and cytoplasmic dynein work in an antagonistic rela-
tionship to regulate MT entry into filopodia. A similar antago-
nistic relationship is observed in measurements of axonal
length (see Figure S2).
Several earlier studies demonstrated that the dynamic prop-
erties of MTs are important for determining whether they can
enter filopodia during growth-cone turning [13–16]. We
analyzed the relative roles of motor-driven forces and MT
dynamics in determining MT distribution in growth cones by
determining the MT levels in the P-domain of growth cones
that had been treated with 5 nM vinblastine after depletion of
dynein by siRNA or inhibition of kinesin-5 with monastrol. At
this low concentration, vinblastine dampens MT dynamics
without causing detectable MT loss [7]. The results show
that no matter the experimental manipulation of DHC or kine-
sin-5, treatment with vinblastine results in a statistically indis-
tinguishable low level of MTs in the P-domain (see Figure S3).
These results suggest that forces generated by molecular
motors make up one element in a multitiered mechanism
that also includes the dynamic properties of the MTs.
The fact that MTs are able to overcome the retrograde flow
of actin when both cytoplasmic dynein and kinesin-5 are sup-
pressed may indicate that the assembly properties of the MTs
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1975Figure 3. Distribution and Phosphorylation of Kinesin-5 in Growth Cones
(A and B) Fluorescence micrographs of growth cones stained with total kinesin-5 antibody (A) and phospho-kinesin-5 antibody (B). (A) Growth cone stained
for total kinesin-5; (A0) the same growth cone, stained for MTs; and (A00) the overlay of A and A0. (B) Growth cone stained for phospho-kinesin-5; (B0) the same
growth cone, stained for MTs; and (B00) the overlay of kinesin5 and MT. The box in (B0) is shown in higher magnification in ‘‘P.’’ Green arrowheads in ‘‘P’’ show
the MTs in the P-domain, and the red region shows phospho-kinesin-5. The blue squiggly line indicates the perimeter of the P-domain. Scale bar represents
5 mm.
(C) Quantification of the polarized distribution of kinesin-5 in growth cones. The ratio of one side of kinesin-5 levels to the other is shown for growth cones
immunostained with antibodies for total kinesin-5 (brown bar) and phospho-kinesin-5 (orange bar). Asterisk denotes p % 0.01. Data represented as
mean + SEM.
(D) Quantification of the levels of kinesin-5 in the T-zone, C-domain, and axonal shaft. The values are ratioed against the levels of MTs in the same region.
Brown bars indicate total kinesin-5, and the orange bar indicates phospho-kinesin-5. Asterisk denotes p% 0.05. Data represented as mean + SEM.
(E) Quantification of the levels of phospho-kinesin-5 and MTs on each half of the growth cones. Red bars indicate the levels of phospho-kinesin-5, and green
bars indicate the levels of MTs on that side of the growth cone in the P-domain. Single asterisk denotes p% 0.05; double asterisk denotes p% 0.005. Data
represented as mean + SEM.are sufficient for overcoming the retrograde flow as long as the
forces generated by the two opposing motors are eliminated.
Alternatively, there may be other motors that contribute to
the capacity of the MTs to overcome the retrograde flow.
During mitosis, MTs are regulated by a variety of motor-driven
forces that act together with the dynamic properties of the MTs
[17], and the same might be true of growth cones.
Distribution and Phosphorylation of Kinesin-5
in the Growth Cone
Kinesin-5 is a homotetrameric motor protein that functions by
generating forces between neighboring MTs [18]. In mitosis,
the interaction of the motor protein with MTs is promoted by
phosphorylation at amino acid 927 [19, 20]. To investigate
whether phosphorylation at this site regulates kinesin-5 in
growth cones, we conducted studies with an antibody thatrecognizes total kinesin-5 and an antibody that recognizes
only phospho-kinesin-5. Virtually all growth cones showed
prominent staining for total kinesin-5, whereas the intensity
of staining for phospho-kinesin-5 varied. Our general sense
was that axons that had been growing straight displayed the
least phospho-kinesin-5 in their growth cones, whereas axons
that were in the process of turning showed the most phospho-
kinesin-5. Figures 3A and 3B show micrographs of growth
cones of cultured neurons double-labeled for MTs with each
of the two kinesin-5 antibodies. Immunostaining with the total
kinesin-5 antibody shows that kinesin-5 is present in the axo-
nal shaft and diffusely throughout the growth cone but is
strongly enriched in the T-zone (Figure 3A). Staining with the
total kinesin-5 antibody shows a significantly higher ratio of
kinesin-5 to MTs in the T-zone (0.744 6 0.11) as compared to
the C-domain (0.145 6 0.03) (p % 0.005, two-tailed t test)
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1976Figure 4. Distribution of Phospho-Kinesin-5 in
Growth Cones in the Border Assay
(A–C) Growth cones stained for MTs (green) and
phospho-kinesin-5 (red) at different stages of
the laminin (blue)-polylysine (white dotted line)
border preparation. The leading edges of the
growth cones are shown with a pink dotted line.
A white arrow denotes the localization of phos-
pho-kinesin-5. (A) Growth cone that has not
encountered the border. (B) Growth cone that
has contacted the border. (C) Growth cone that
has made a turn at the border.
(D) Quantification of the percentage of growth
cones that show localization of phospho-kine-
sin-5. A red bar indicates growth cones that
have not reached the border, a green bar
indicates growth cones that have contacted the
border, and a blue bar indicates the growth cones
that have already turned. Asterisk denotes p %
0.001. Scale bar represents 5 mm.
(E) Illustration of how forces exerted by different
motor proteins may act during growth-cone
turning. Arrows show the direction of the forces
exerted by each motor. Dynein-based forces
(red arrows) enable MTs to enter into the
P-domain by opposing myosin-II-based forces
(blue arrowheads). Kinesin-5 (purple and pink) is
enriched in the T-zone, but its phosphorylation
state may exhibit asymmetry across the growth
cone (purple, high phosphorylation; pink, low
phosphorylation). It becomes more phosphory-
lated on the side opposite the direction of turning
(purple). When phosphorylated, kinesin-5 is able
to generate forces (purple with blue arrows) in
the T-zone that oppose the dynein-based forces.
As a result, the MTs preferentially invade the
P-domain on the side of the growth cone where
kinesin-5 is less phosphorylated (pink). This scenario is consistent with our previously proposed model, in which the forces that influence the distribution
of long MTs in growth cones are generated by the same motor proteins that regulate the transport of short MTs within the axonal shaft [21].and the axonal shaft (0.2226 0.03, n = 5) (p% 0.05, two-tailed
t test). The ratio of phospho-kinesin-5 to MTs was also higher
in the T-zone (1.48 6 0.37) as compared to the C-domain
(0.1386 0.012) (p% 0.05, two-tailed t test) and the axonal shaft
(0.099 6 0.02, n = 6) (p % 0.05, two-tailed t test). Also, in the
T-zone, the ratio of the phospho-kinesin-5 to MTs is much
higher than the ratio of total kinesin-5 to MTs. This suggests
that a far greater proportion of the kinesin-5 in the T-zone is
phosphorylated, as compared to the kinesin-5 in the axonal
shaft and the C-domain (Figure 3D).
Whereas the total kinesin-5 antibody stained throughout the
T-zone, the phospho-kinesin-5 antibody tended to stain more
strongly in the T-zone on one of the growth-cone sides
(Figure 3B). To quantify this, we divided the growth cone into
equal halves and calculated the ratio of fluorescence intensity
between the two halves. The ratio for total kinesin-5 is 1.15
(n = 10), showing a slight tendency to polarize, whereas the
ratio for phospho-kinesin-5 is 1.74 (n = 9), showing a stronger
tendency to polarize (Figure 3C) (p % 0.01, two-tailed t test).
Of particular interest, when we quantified MT levels on each
half of the growth cones, we found that the half that showed
an enrichment of phospho-kinesin-5 (832.496 110.61) showed
lower levels of MTs entering the adjacent P-domain (249.04 6
48.86) as compared to MT levels in the P-domain on the other
half of the growth cone (485.11 6 80.44, n = 9) (p % 0.05,
two-tailed t test) that showed lower levels of phospho-kine-
sin-5 (259.55 6 52.66) (p% 0.005, two-tailed t test) (Figure 3E,
see also ‘‘P’’ in Figure 3B).On the basis of these observations, we hypothesize that ki-
nesin-5 is mainly nonphosphorylated before the growth cone
is challenged to turn and after a turn has been completed
but becomes phosphorylated when the growth cone is
presented with a turning cue. If this is correct, polarization of
phospho-kinesin-5 should occur even before the MT array
becomes polarized and before the growth cone displays
morphological indications of a turning response. To test these
predictions, we analyzed the localization of phospho-kinesin-5
in a modified border assay (see Supplemental Experimental
Procedures). We chose axons that had been growing straight
toward the border but (1) had not yet reached it, (2) had just
reached the border but showed no indication of turning yet,
or (3) had completed turning in response to the border. As pre-
dicted, the first (n = 13) and third (n = 19) categories displayed
very little phospho-kinesin-5 in their growth cones (Figures 4A
and 4C). In sharp contrast, and also as predicted, prominent
and highly polarized staining for phospho-kinesin-5 was
detected in the second category of growth cones (n = 16,
p % 0.001, chi-square test) (Figure 4B; see Figure 4D also).
These observations are consistent with a mechanism by which
kinesin-5 is phosphorylated in a polarized fashion when the
growth cone is challenged to turn, a critical event for the
subsequent polarization of the MT array underlying growth-
cone turning (Figure 4E).
In conclusion, the studies reported here demonstrate that
kinesin-5 plays an essential role in polarizing the MT array in
response to cues that cause the growth cone to turn.
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1977Supplemental Data
Supplemental Data include Supplemental Experimental Procedures, five
figures, and six movies and can be found with this paper online at http://
www.current-biology.com/supplemental/S0960-9822(08)01501-7.
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